Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 8/2014

01.12.2014 | Original Article

Liver failure after hepatocellular carcinoma surgery

verfasst von: Hiroaki Motoyama, Akira Kobayashi, Takahide Yokoyama, Akira Shimizu, Norihiko Furusawa, Hiroshi Sakai, Noriyuki Kitagawa, Yohei Ohkubo, Teruomi Tsukahara, Shin-ichi Miyagawa

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to construct a prediction model for posthepatectomy liver failure (PHLF), as defined by the International Study Group of Liver Surgery, and evaluate its accuracy in hepatocellular carcinoma (HCC) patients with cirrhosis or chronic hepatitis.

Methods

A total of 277 consecutive hepatectomies for HCC between 2005 and 2013 were analyzed retrospectively. Multivariate logistic regression analysis was used to develop a predictive model for PHLF. The sensitivity, specificity, and area under the receiver operating characteristic (AUROC) curve were evaluated. The Hosmer–Lemeshow goodness-of-fit test was used to assess the model calibration. The constructed model was internally validated by k-fold cross-validation (k = 5).

Results

PHLF developed in 12.6 % of hepatectomies. Multivariate analysis identified the following variables as predictors of PHLF: elevated preoperative serum bilirubin level, elevated preoperative international normalized ratio, and intraoperative packed red blood cell transfusion. The predictive model allowed discrimination between patients who developed PHLF and those who did not, with a sensitivity of 82.9 %, specificity of 72.3 %, and AUROC curve of 0.81 (95 % CI, 0.74 to 0.89). The Hosmer–Lemeshow test indicated a good fit (P = 0.545). The AUROC curve of the developed model was significantly greater than that of the model for end-stage liver disease (MELD) score (P = 0.014), suggesting that the former model is better at predicting the PHLF than the latter one.

Conclusions

The developed model could be useful for predicting the occurrence of PHLF in HCC patients with underlying liver disease.
Literatur
1.
Zurück zum Zitat Michel J, Suc B, Montpeyroux F, Hachemanne S, Blanc P, Domergue J, Mouiel J, Gouillat C, Ducerf C, Saric J, Le Treut YP, Fourtanier G, Escat J (1997) Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J Hepatol 26:1274–1280PubMedCrossRef Michel J, Suc B, Montpeyroux F, Hachemanne S, Blanc P, Domergue J, Mouiel J, Gouillat C, Ducerf C, Saric J, Le Treut YP, Fourtanier G, Escat J (1997) Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J Hepatol 26:1274–1280PubMedCrossRef
2.
Zurück zum Zitat Dmitrewski J, El-Gazzaz G, McMaster P (1998) Hepatocellular cancer: resection or transplantation. J Hepatobiliary Pancreat Surg 5:18–23PubMedCrossRef Dmitrewski J, El-Gazzaz G, McMaster P (1998) Hepatocellular cancer: resection or transplantation. J Hepatobiliary Pancreat Surg 5:18–23PubMedCrossRef
3.
Zurück zum Zitat Sarasin FP, Giostra E, Mentha G, Hadengue A (1998) Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective. Hepatology 28:436–442PubMedCrossRef Sarasin FP, Giostra E, Mentha G, Hadengue A (1998) Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective. Hepatology 28:436–442PubMedCrossRef
4.
Zurück zum Zitat Figueras J, Jaurrieta E, Valls C, Ramos E, Serrano T, Rafecas A, Fabregat J, Torras J (2000) Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg 190:580–587PubMedCrossRef Figueras J, Jaurrieta E, Valls C, Ramos E, Serrano T, Rafecas A, Fabregat J, Torras J (2000) Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg 190:580–587PubMedCrossRef
5.
Zurück zum Zitat Majno PE, Sarasin FP, Mentha G, Hadengue A (2000) Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology 31:899–906PubMedCrossRef Majno PE, Sarasin FP, Mentha G, Hadengue A (2000) Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology 31:899–906PubMedCrossRef
6.
Zurück zum Zitat Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, Koch M, Makuuchi M, Dematteo RP, Christophi C, Banting S, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey JN, Greig P, Rees M, Yokoyama Y, Fan ST, Nimura Y, Figueras J, Capussotti L, Buchler MW, Weitz J (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713–724PubMedCrossRef Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, Koch M, Makuuchi M, Dematteo RP, Christophi C, Banting S, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey JN, Greig P, Rees M, Yokoyama Y, Fan ST, Nimura Y, Figueras J, Capussotti L, Buchler MW, Weitz J (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713–724PubMedCrossRef
7.
Zurück zum Zitat Cohnert TU, Rau HG, Buttler E, Hernandez-Richter T, Sauter G, Reuter C, Schildberg FW (1997) Preoperative risk assessment of hepatic resection for malignant disease. World J Surg 21:396–400, discussion 401PubMedCrossRef Cohnert TU, Rau HG, Buttler E, Hernandez-Richter T, Sauter G, Reuter C, Schildberg FW (1997) Preoperative risk assessment of hepatic resection for malignant disease. World J Surg 21:396–400, discussion 401PubMedCrossRef
8.
Zurück zum Zitat Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM (1998) Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 2:292–298PubMedCrossRef Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM (1998) Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 2:292–298PubMedCrossRef
9.
Zurück zum Zitat Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38–46PubMedCrossRef Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38–46PubMedCrossRef
10.
Zurück zum Zitat Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759–766PubMedCentralPubMedCrossRef Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759–766PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S, Blumgart LH (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236:397–406, discussion 406–397PubMedCentralPubMedCrossRef Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S, Blumgart LH (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236:397–406, discussion 406–397PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, Takayama T, Makuuchi M (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138:1198–1206, discussion 1206PubMedCrossRef Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, Takayama T, Makuuchi M (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138:1198–1206, discussion 1206PubMedCrossRef
13.
Zurück zum Zitat Schindl MJ, Redhead DN, Fearon KC, Garden OJ, Wigmore SJ, Edinburgh Liver S, Transplantation Experimental Research G (2005) The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 54:289–296PubMedCentralPubMedCrossRef Schindl MJ, Redhead DN, Fearon KC, Garden OJ, Wigmore SJ, Edinburgh Liver S, Transplantation Experimental Research G (2005) The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 54:289–296PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, Visa J, Bru C, Rodes J (1996) Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111:1018–1022PubMedCrossRef Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, Visa J, Bru C, Rodes J (1996) Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111:1018–1022PubMedCrossRef
15.
Zurück zum Zitat Ghany MG, Lok AS, Everhart JE, Everson GT, Lee WM, Curto TM, Wright EC, Stoddard AM, Sterling RK, Di Bisceglie AM, Bonkovsky HL, Morishima C, Morgan TR, Dienstag JL (2010) Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C. Gastroenterology 138:136–146PubMedCentralPubMedCrossRef Ghany MG, Lok AS, Everhart JE, Everson GT, Lee WM, Curto TM, Wright EC, Stoddard AM, Sterling RK, Di Bisceglie AM, Bonkovsky HL, Morishima C, Morgan TR, Dienstag JL (2010) Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C. Gastroenterology 138:136–146PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Kumar R, Shalimar SH, Goyal R, Kumar A, Khanal S, Prakash S, Gupta SD, Panda SK, Acharya SK (2012) Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure. Gut 61:1068–1075PubMedCrossRef Kumar R, Shalimar SH, Goyal R, Kumar A, Khanal S, Prakash S, Gupta SD, Panda SK, Acharya SK (2012) Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure. Gut 61:1068–1075PubMedCrossRef
17.
Zurück zum Zitat Barton JS, Riha GM, Differding JA, Underwood SJ, Curren JL, Sheppard BC, Pommier RF, Orloff SL, Schreiber MA, Billingsley KG (2013) Coagulopathy after a liver resection: is it over diagnosed and over treated? HPB (Oxford) Barton JS, Riha GM, Differding JA, Underwood SJ, Curren JL, Sheppard BC, Pommier RF, Orloff SL, Schreiber MA, Billingsley KG (2013) Coagulopathy after a liver resection: is it over diagnosed and over treated? HPB (Oxford)
18.
Zurück zum Zitat Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, Durand F (2005) The “50-50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 242:824–828, discussion 828–829PubMedCentralPubMedCrossRef Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, Durand F (2005) The “50-50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 242:824–828, discussion 828–829PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, Abdalla EK, Curley SA, Capussotti L, Clary BM, Vauthey JN (2007) Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 204:854–862, discussion 862–854PubMedCrossRef Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, Abdalla EK, Curley SA, Capussotti L, Clary BM, Vauthey JN (2007) Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 204:854–862, discussion 862–854PubMedCrossRef
20.
Zurück zum Zitat Nagai S, Fujimoto Y, Kamei H, Nakamura T, Kiuchi T (2009) Mild hepatic macrovesicular steatosis may be a risk factor for hyperbilirubinaemia in living liver donors following right hepatectomy. Br J Surg 96:437–444PubMedCrossRef Nagai S, Fujimoto Y, Kamei H, Nakamura T, Kiuchi T (2009) Mild hepatic macrovesicular steatosis may be a risk factor for hyperbilirubinaemia in living liver donors following right hepatectomy. Br J Surg 96:437–444PubMedCrossRef
21.
Zurück zum Zitat Fukumori D, Kamiyama T, Nakanishi K, Yokoo H, Tahara M, Kamachi H, Matsushita M, Todo S (2011) Analysis of risk factors for hyperbilirubinemia occurring after hepatectomy. J Hepatobiliary Pancreat Sci 18:724–730PubMedCrossRef Fukumori D, Kamiyama T, Nakanishi K, Yokoo H, Tahara M, Kamachi H, Matsushita M, Todo S (2011) Analysis of risk factors for hyperbilirubinemia occurring after hepatectomy. J Hepatobiliary Pancreat Sci 18:724–730PubMedCrossRef
22.
Zurück zum Zitat Lei JY, Yan LN, Wang WT (2013) Prediction factors of postoperative hyperbilirubinemia in living right lobe donor: a single-center analysis of 210 cases. Transplant Proc 45:205–211PubMedCrossRef Lei JY, Yan LN, Wang WT (2013) Prediction factors of postoperative hyperbilirubinemia in living right lobe donor: a single-center analysis of 210 cases. Transplant Proc 45:205–211PubMedCrossRef
23.
Zurück zum Zitat Bolder U, Tacke J, Imhoff M, Lohlein D (1993) Postoperative course of functional and cellular variables in liver resection. Scand J Gastroenterol 28:949–957PubMedCrossRef Bolder U, Tacke J, Imhoff M, Lohlein D (1993) Postoperative course of functional and cellular variables in liver resection. Scand J Gastroenterol 28:949–957PubMedCrossRef
24.
Zurück zum Zitat Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, Kawasaki S (1993) Surgery for small liver cancers. Semin Surg Oncol 9:298–304PubMedCrossRef Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, Kawasaki S (1993) Surgery for small liver cancers. Semin Surg Oncol 9:298–304PubMedCrossRef
25.
Zurück zum Zitat Couinaud C (1957) Le foie. Etudes anatomiques et chirurgicales. Masson, Paris Couinaud C (1957) Le foie. Etudes anatomiques et chirurgicales. Masson, Paris
26.
Zurück zum Zitat Makuuchi M, Torzilli G, Machi J (1998) History of intraoperative ultrasound. Ultrasound Med Biol 24:1229–1242PubMedCrossRef Makuuchi M, Torzilli G, Machi J (1998) History of intraoperative ultrasound. Ultrasound Med Biol 24:1229–1242PubMedCrossRef
27.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedCentralPubMedCrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedCentralPubMedCrossRef
28.
Zurück zum Zitat Lemeshow S, Hosmer DW Jr (1982) A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 115:92–106PubMed Lemeshow S, Hosmer DW Jr (1982) A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 115:92–106PubMed
29.
Zurück zum Zitat Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864–871PubMedCrossRef Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864–871PubMedCrossRef
30.
Zurück zum Zitat DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845PubMedCrossRef DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845PubMedCrossRef
31.
Zurück zum Zitat Freeman RB Jr, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, Merion R, Wolfe R, Turcotte J, Teperman L (2002) The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 8:851–858PubMedCrossRef Freeman RB Jr, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, Merion R, Wolfe R, Turcotte J, Teperman L (2002) The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 8:851–858PubMedCrossRef
32.
Zurück zum Zitat Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Muller M (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinforma 12:77CrossRef Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Muller M (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinforma 12:77CrossRef
33.
Zurück zum Zitat Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, Harihara Y, Takayama T (1997) Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 26:1176–1181PubMed Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, Harihara Y, Takayama T (1997) Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 26:1176–1181PubMed
34.
Zurück zum Zitat Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, La Barba G, Zanello M, Grazi GL, Pinna AD (2006) Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 12:966–971PubMedCrossRef Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, La Barba G, Zanello M, Grazi GL, Pinna AD (2006) Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 12:966–971PubMedCrossRef
35.
Zurück zum Zitat Yang T, Zhang J, Lu JH, Yang GS, Wu MC, Yu WF (2011) Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg 35:2073–2082PubMedCrossRef Yang T, Zhang J, Lu JH, Yang GS, Wu MC, Yu WF (2011) Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg 35:2073–2082PubMedCrossRef
36.
Zurück zum Zitat Chen X, Zhai J, Cai X, Zhang Y, Wei L, Shi L, Wu D, Shen F, Lau WY, Wu M (2012) Severity of portal hypertension and prediction of postoperative liver failure after liver resection in patients with Child-Pugh grade A cirrhosis. Br J Surg 99:1701–1710PubMedCrossRef Chen X, Zhai J, Cai X, Zhang Y, Wei L, Shi L, Wu D, Shen F, Lau WY, Wu M (2012) Severity of portal hypertension and prediction of postoperative liver failure after liver resection in patients with Child-Pugh grade A cirrhosis. Br J Surg 99:1701–1710PubMedCrossRef
37.
Zurück zum Zitat Squires MH, 3rd, Dann GC, Lad NL, Fisher SB, Martin BM, Kooby DA, Sarmiento JM, Russell MC, Cardona K, Staley CA, 3rd, Maithel SK (2014) Hypophosphataemia after major hepatectomy and the risk of post-operative hepatic insufficiency and mortality: an analysis of 719 patients. HPB (Oxford) Squires MH, 3rd, Dann GC, Lad NL, Fisher SB, Martin BM, Kooby DA, Sarmiento JM, Russell MC, Cardona K, Staley CA, 3rd, Maithel SK (2014) Hypophosphataemia after major hepatectomy and the risk of post-operative hepatic insufficiency and mortality: an analysis of 719 patients. HPB (Oxford)
38.
Zurück zum Zitat Sitzmann JV, Greene PS (1994) Perioperative predictors of morbidity following hepatic resection for neoplasm. A multivariate analysis of a single surgeon experience with 105 patients. Ann Surg 219:13–17PubMedCentralPubMedCrossRef Sitzmann JV, Greene PS (1994) Perioperative predictors of morbidity following hepatic resection for neoplasm. A multivariate analysis of a single surgeon experience with 105 patients. Ann Surg 219:13–17PubMedCentralPubMedCrossRef
39.
Zurück zum Zitat Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J (2004) Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 240:698–708, discussion 708–610PubMedCentralPubMed Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J (2004) Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 240:698–708, discussion 708–610PubMedCentralPubMed
40.
Zurück zum Zitat Fukushima K, Fukumoto T, Kuramitsu K, Kido M, Takebe A, Tanaka M, Itoh T, Ku Y (2014) Assessment of ISGLS definition of posthepatectomy liver failure and its effect on outcome in patients with hepatocellular carcinoma. J Gastrointest Surg 18:729–736PubMedCrossRef Fukushima K, Fukumoto T, Kuramitsu K, Kido M, Takebe A, Tanaka M, Itoh T, Ku Y (2014) Assessment of ISGLS definition of posthepatectomy liver failure and its effect on outcome in patients with hepatocellular carcinoma. J Gastrointest Surg 18:729–736PubMedCrossRef
41.
Zurück zum Zitat Ribeiro HS, Costa WL Jr, Diniz AL, Godoy AL, Herman P, Coudry RA, Begnami MD, Mello CA, Silva MJ, Zurstrassen CE, Coimbra FJ (2013) Extended preoperative chemotherapy, extent of liver resection and blood transfusion are predictive factors of liver failure following resection of colorectal liver metastasis. Eur J Surg Oncol 39:380–385PubMedCrossRef Ribeiro HS, Costa WL Jr, Diniz AL, Godoy AL, Herman P, Coudry RA, Begnami MD, Mello CA, Silva MJ, Zurstrassen CE, Coimbra FJ (2013) Extended preoperative chemotherapy, extent of liver resection and blood transfusion are predictive factors of liver failure following resection of colorectal liver metastasis. Eur J Surg Oncol 39:380–385PubMedCrossRef
42.
Zurück zum Zitat Nanashima A, Abo T, Arai J, Matsumoto H, Kudo T, Nagayasu T (2013) Functional liver reserve parameters predictive for posthepatectomy complications. J Surg Res 185:127–135PubMedCrossRef Nanashima A, Abo T, Arai J, Matsumoto H, Kudo T, Nagayasu T (2013) Functional liver reserve parameters predictive for posthepatectomy complications. J Surg Res 185:127–135PubMedCrossRef
43.
Zurück zum Zitat Allard MA, Adam R, Bucur PO, Termos S, Cunha AS, Bismuth H, Castaing D, Vibert E (2013) Posthepatectomy portal vein pressure predicts liver failure and mortality after major liver resection on noncirrhotic liver. Ann Surg 258:822–829, discussion 829–830PubMedCrossRef Allard MA, Adam R, Bucur PO, Termos S, Cunha AS, Bismuth H, Castaing D, Vibert E (2013) Posthepatectomy portal vein pressure predicts liver failure and mortality after major liver resection on noncirrhotic liver. Ann Surg 258:822–829, discussion 829–830PubMedCrossRef
44.
Zurück zum Zitat Capussotti L, Vigano L, Giuliante F, Ferrero A, Giovannini I, Nuzzo G (2009) Liver dysfunction and sepsis determine operative mortality after liver resection. Br J Surg 96:88–94PubMedCrossRef Capussotti L, Vigano L, Giuliante F, Ferrero A, Giovannini I, Nuzzo G (2009) Liver dysfunction and sepsis determine operative mortality after liver resection. Br J Surg 96:88–94PubMedCrossRef
45.
Zurück zum Zitat Rahman SH, Evans J, Toogood GJ, Lodge PA, Prasad KR (2008) Prognostic utility of postoperative creactive protein for posthepatectomy liver failure. Arch Surg 143:247–253, discussion 253PubMedCrossRef Rahman SH, Evans J, Toogood GJ, Lodge PA, Prasad KR (2008) Prognostic utility of postoperative creactive protein for posthepatectomy liver failure. Arch Surg 143:247–253, discussion 253PubMedCrossRef
46.
Zurück zum Zitat Kubo S, Tsukamoto T, Hirohashi K, Tanaka H, Shuto T, Takemura S, Yamamoto T, Uenishi T, Ogawa M, Kinoshita H (2004) Correlation between preoperative serum concentration of type IV collagen 7s domain and hepatic failure following resection of hepatocellular carcinoma. Ann Surg 239:186–193PubMedCentralPubMedCrossRef Kubo S, Tsukamoto T, Hirohashi K, Tanaka H, Shuto T, Takemura S, Yamamoto T, Uenishi T, Ogawa M, Kinoshita H (2004) Correlation between preoperative serum concentration of type IV collagen 7s domain and hepatic failure following resection of hepatocellular carcinoma. Ann Surg 239:186–193PubMedCentralPubMedCrossRef
47.
Zurück zum Zitat Shoup M, Gonen M, D'Angelica M, Jarnagin WR, DeMatteo RP, Schwartz LH, Tuorto S, Blumgart LH, Fong Y (2003) Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 7:325–330PubMedCrossRef Shoup M, Gonen M, D'Angelica M, Jarnagin WR, DeMatteo RP, Schwartz LH, Tuorto S, Blumgart LH, Fong Y (2003) Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 7:325–330PubMedCrossRef
48.
Zurück zum Zitat Makuuchi M, Takayama T, Gunven P, Kosuge T, Yamazaki S, Hasegawa H (1989) Restrictive versus liberal blood transfusion policy for hepatectomies in cirrhotic patients. World J Surg 13:644–648PubMedCrossRef Makuuchi M, Takayama T, Gunven P, Kosuge T, Yamazaki S, Hasegawa H (1989) Restrictive versus liberal blood transfusion policy for hepatectomies in cirrhotic patients. World J Surg 13:644–648PubMedCrossRef
49.
Zurück zum Zitat Yamanaka N, Okamoto E, Kuwata K, Tanaka N (1984) A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg 200:658–663PubMedCentralPubMedCrossRef Yamanaka N, Okamoto E, Kuwata K, Tanaka N (1984) A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg 200:658–663PubMedCentralPubMedCrossRef
50.
Zurück zum Zitat Subramanian J, Simon R (2013) Overfitting in prediction models - is it a problem only in high dimensions? Contemp Clin Trials 36:636–641PubMedCrossRef Subramanian J, Simon R (2013) Overfitting in prediction models - is it a problem only in high dimensions? Contemp Clin Trials 36:636–641PubMedCrossRef
51.
Zurück zum Zitat Northup PG, Wanamaker RC, Lee VD, Adams RB, Berg CL (2005) Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg 242:244–251PubMedCentralPubMedCrossRef Northup PG, Wanamaker RC, Lee VD, Adams RB, Berg CL (2005) Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg 242:244–251PubMedCentralPubMedCrossRef
52.
Zurück zum Zitat Teh SH, Nagorney DM, Stevens SR, Offord KP, Therneau TM, Plevak DJ, Talwalkar JA, Kim WR, Kamath PS (2007) Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 132:1261–1269PubMedCrossRef Teh SH, Nagorney DM, Stevens SR, Offord KP, Therneau TM, Plevak DJ, Talwalkar JA, Kim WR, Kamath PS (2007) Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 132:1261–1269PubMedCrossRef
Metadaten
Titel
Liver failure after hepatocellular carcinoma surgery
verfasst von
Hiroaki Motoyama
Akira Kobayashi
Takahide Yokoyama
Akira Shimizu
Norihiko Furusawa
Hiroshi Sakai
Noriyuki Kitagawa
Yohei Ohkubo
Teruomi Tsukahara
Shin-ichi Miyagawa
Publikationsdatum
01.12.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 8/2014
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-014-1252-0

Weitere Artikel der Ausgabe 8/2014

Langenbeck's Archives of Surgery 8/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.